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Children who attend day-care centers run all increased risk ofexposure to
the highly contagious bacterium Baemophilus influenzae type b (Bib), a
common cause ofmeningitis - a severe infection ofbrain and spinal cord
membranes. Afortunate meningitis recoverer, Matthew Martin (right),
plays at a St. Louis area day-care center with Andrew Bums, a recent par
ticipant in clinical trials for a new vaccine against Bib directed by Dan
M. Granoff, M.D., at Washington University School ofMedicine. See stQry,
page 4.
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Brain damage associated with Alzheimer's disease,
Huntington's chorea, epilepsy and other well known
neurological disorders may be the result of a neurotrans
mitter called glutamate that also is a potential toxin.
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AIDS Against Itself'

17

Together with Robert C. Gallo at the National Cancer
Institute, Lee Ratner has developed two mutant forms
of the AIDS virus that may be used in the future to
"vaccinate" patients already infected with AIDS, as well
as to learn more about how this deadly virus cripples
immune cells.

Henrv Sehwartz's Constellation of
Fortu"itous Events

20

Outlook profiles one of the most esteemed neurosUf
geons in the world, reflecting on his research contribu
tions and his creation of the renowned neurosurgery
training program at Washington University.
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the direction of Urban C
Bcrgbauer, trustee, the founda
tion ha~ donated more than
$500,000 tt) thl:! departmen t '~
protein synthesizing facility. •
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<ltti M. Nem<!th, Ph ,D.,
associat<! research pro
ks. or of neurology amI
of anatomy and neurobiology,
has been awarded more than
~526,OOO in two grams from
the Nationallnstitlltes of
Health _
The first awa rd is from the
National Jn~titute of Neurology
ami Conn.tlIniCalivc Disorders
~md Stroke and will fund a
project on the biochemistry
and physiology of single axons
and the set of muscle filxrs
they simulate_Nemeth and her
tcam have developed a tech
nique tor measuring energy
metabolism, anatomical
arrangell1entllnd physiologkal
properties of these mdividual
"motor un its_" The technique
enables Neill th to compare
prec isely the biochemical amI
physical make-up of rou de
and the physiological charac
teristics of its nerve.
The second award is from
the National Institute of Ar
thritis. Diabetes. Digestive and
Kidney Diseases tiJr a study 01
neural influences on the bio
chemistry ot single muscle
fiber -_In thl research, Nemeth
tests the extent to whieh neural
and n In-ncural factors - such
as hormonal factor, - affect
muscle during development.
anu how fully mature llIuscles
can be aJtered hy long -teml
exercise or by programmed
contrac tions induced with
artificictl stimulation _
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oseph L. Roti Roti , Ph.D.,
associate professor of ra
diology. has been awarded
$200.657 [ron th Nationa l
am:er Institute in the form of
two research grants to study
the effe ts of hy perthermia
the use of heat to shrink
cancerous tumors - on cell
~t ruct ure.

Gregory A. Grant, Ph.D., assistant professor ofbiochemistry 11lld
medicine, explaills the finer points ofthe protein chemistry lab's
new peptide synthesizer to Carl Friedm, Ph .D.
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$140,000 gift from the
Whitaker haritable
Foundation has enabled
the Depllrtmcnt of Biological
Chemistry to purchase a new
peptide synthesi7er for its prf}-
tein sequencing facility.
Serving as a companion
instrument to the apor phase
protein sequencing system.
whieh was purChased last year
from an earlier Whitaker foun
dation gift. the peptide synthe
sizer is expected to open up
many research possibilities at
Washington University, <.Iccord
ing to Carl Frieden. Ph _D..
prorcs~or anll interi m heau of
the tlepartl1lcnL
The instrument will be

e~pecial l y u~eful

in Friellen's
work, which wa<; recently
awarded di<;tinguished MERIT
status by the NatIOnal Institute
of Diabetes and Digestive
Kidney Diseases_ Such designa
tion provides a few outstanding
invest i gato~ with long-tem1
~lable support. allowing them
to continue their investigations
without many of the adminis
trative burdens a! socialed with
the preparation and suhmission
of grant application~_
"With this new instrument,
we can synthesi7.e pcptides
against which antibodies could
be prepared and targeted to
specific malignant cells and not
to other cells," Frieden say. _
The new instrument should
also aill investigation into cellu
I<u' func tions such as motility,
cytoskeletal structure, endocy
tosis and cell division _Under

The lir;;t grant wi ll allow
Roti Roti and co-researchers
to study the effects of radiat ion
and hyperthermia on nuclear
organization and function _
In particular, the six-year Mudy
is aimed at de.ermining
whether or not heat and x ray
induced changes inhibit cell
reproduction .
The sct·ond grant wi ll
enable him to study the corre
lation belwe n heat-inuuced
change in nuclear protein~ and
growth dela in anceroll s
tumors. "Our ovemll goal," he
says, "i to explain the biologi 
cal mechanism of therapeutic
methods."
Roti Roti Wjj~ an a<;soc iate
professor of radiology at the
University of Utah School of
Medicine in Salt Lake City be
fore being appoi nted to hi ~ pre
sent po!)ition althe university
in 1985. He i-; th recipient of a
number of research grants in
cell kinetics and structure and
has contributed nearly 50
publications to the literature
of biophysics.
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: ew II i h '~H'('i nc'
linical trials of a new
vaccme agamst
Haemophilus influen
zae type b (Hib) - a bacterium
responsible for bacterial
meningitis and a number of
other life-threatening child
hood illnesses - show that the
new vaccine for the first time
affords protection in infants
from two to six months of age.
"This study marks the first
time an~ vaccine has produced
antibody levels considered
capable of protecting infants as
young as two months," says
Dan M. Granoff, M.D., profes
sor of pediatrics and associate
professor of microbiology and
immunology.
"Of the 63 chi Idren we im
munized, 25 were 8-17 months
old and 38 were younger than
six months," Granoff says. "In
most cases, even a single injec
tion raised antibody levels
among infants younger than six
months higher than those pro
duced by any other Hib
vaccine."
Robert Daum, M.D., head
of pediatric infectious diseases
at Tulane University, calls
Granoff's work "groundbreak
ing. The exciting thing is that
this new vaccine looks fantasti
cally immunogenic, capable of
protecting young children at
their peak susceptibility to the
disease." Daum is a me mber of
the American Academy of
Pediatrics committee on infec
tious diseases.
"Most of the infants in our
study showed further increases
in antibody after a second in
jection," Granoff continues.
"We're encouraged by these
results because a vaccine that is
effective in thi s keyage group

C

4

'OOi

•
•
• •

•
•

lor

E
.....

'"::t.

•

!
•

•• • •
•

•

0

• •

0
CD

•
• •

foZ

<l

•

•

~

•
•

•
•

~

•
••

I!

I

•••

•

•

•

•
I

I

I

I

I

I

I

I

I

10

20

30

40

50

60

70

80

90

--L

Adults

AGE IN MONTHS

Dan M. GratwfJ, M.D. 's, research team determined the levels of
antibody against Hib bacteria in normaL subjects. Their new
vaccine is effective in children most vulnerable to Hib disease
'
those younger than 24 nwnths.
can confer Hib inununity to
millions of children who aren't
protected by the currently
licensed vaccine, or who'd be
poorly protected even after two
doses of the other unlicensed,
investigational Hib vaccines
tested to date."
The vaccine currently used
against Hib di sease, which was
licensed in 1985 and is pro
duced by several companies,
contains a purified piece of the
Hib bacteria's outer coating,
which is composed of linked
suga rs called polysaccharides.
Thus the currently licensed
vaccine is known as Hib poly
saccharide vaccine or Hib PS.

In a large National Institutes
of Health-sponsored clinical
trial , this Hib PS vaccine pro
duced significant antibody
levels in older children but was
found to be totally ineffective
in infants less than 18 months
old, the age grou p at highest
risk for Hib disease.
In 1984, representatives
from Merck Sharp and Dohme
asked Granoff's team of sea
soned investigators - who'd
tested the Hib PS vaccine and
who were experienced in evalu
ating responses to immuniza
tion - to test a new vaccine :
an Hib PS protein conjugate.
In the new vaccine, Hib PS

is li nked to a protein pu rified
from a meningococcu s bacteria
which, like Hi b, is al so known
to cause meningitis. T his con
jugation of PS to protein
greatly enhances antibody re
sponse within infants. In addi
tion to choosi ng the correct
protein to ac t as a spark plug
for J-Iib PS, researchers also
found a unique way to li nk Hib
PS and protein withou t dis
turbing the Hib PS bacteria
fighting activity
In spite of promising results,
which were recently published
in the prestigious Briti sh
medical journal Lancel, work
must st ill be do ne before the
new vaccine can be licensed .
" We have to determine the op
ti mal dose and immuni zation
schedule," says Geoffrey A .
Weinberg, M.D., a research fel
low and co-author of the Lancet
article. "We' re not ye t sure of
the preci se level of antibody re
quired to provid protection ,
and we have to be w re that the
antibody produced by thi s vac
cination w ill last. "
Granoff's tea m has already
immu nized more than 100 ad
ditional infants si nce comple
tion of the Lancet study. I n this
second trial , infants agai n
produced good anti body levels
with few side effec ts.
Once the exact dosc and
schedule are refined , the next
step is a series of trials in
which thousands of child ren
are vaccinated and monitored
for several years to make sure
they re main immune to Hib.
These trials w ill also detect any
safety proble ms that might
not have appeared in previous
studies.
"We can't yet swear by the
Hib PS -protein conjugate vac
cine," Weinberg says. " but it
looks good, very good .,. •
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onald G. Sessions,
M. D. '62, has be n
named president of the
Washington University Med ical
Center Alumni Association.
An expert on the surgical treat
ment of head and neck cancers,
Sessions is professor of
otolaryngology and director of
resident training for the
otolaryngology department.
Sessions graduated from the
School of Medicine in 1962.
After completing an inte rnship
and residency in surgery at
Vanderbilt Hospital in
Nashville, Tennessee, he
returned to Washington Uni
versity for a residency in
otolaryngology. Following mil
itary service at the U. . Air

-.1,.

Donald G. Sessums, M.D, '62

Force Hospital in Anchorage,
Alaska, he was named assis
tant professor of otolaryngol
ogy at Washington University
in 1970.
Sessions is on staff at
Barnes, Children's and Jewish
hospitals. He is a member of a
number of professional organi
zations, including fellowship
in the American College of Sur
geons, the American Academy
of O tolaryngology - Head
and eck Surgery, the Ameri
can Academy of Facial Plastic
and Reconstructive Surgery
and the American Society for
Head and Neck Surgery. He
has published numerous jour
nal articles in his field and is
the author of a textbook, Atlas
ofLaryngeal Surgery. Sessions
has a special interest in well
being and the doctor-patient
relationship and is currently
doing research in this area. _

PC"IT\'

IlcHlured for

'ltoadlill;,! (;ood
11.'a .o( II.. bib
. Mitchell Perry Jr.,
M. D., professor of
. medicine and director
of the hypertension division,
has received the Louis B.
Russell Jr. Memorial Award
from the American Heart
Assoc iation.
The award recognizes Perry
for outstanding achievement in
educating minorities about life
styles that are healthy for the
heart. Louis Russell, a black
Indianapolis teacher, received a
transplanted heart in 1968 and
was an energetic volunteer for
the American Heart Associa
tion until his death in 1974.
Perry was cited for a project
he created to help solve a major
problem in the St. Louis area:
identifying young, black males
with uncontrolled hypertension
who face potentially fatal med
ical problems. The program
Perry developed began in 1982
and called for door-to-door
canvassing of minority commu
nities to locate and treat people
with high blood pressure. He
directed the project, which was
funded by the St. Louis chapter
of the American Heart Asso
ciation and was a cooperative
community effort involving a
number of educational institu
tions and health organizations.
Perry has been director of
the hypertension division at the
School of Medicine since 1957
He also serves as director of the
hypertension program at the St.
Louis Veterans Administration
Hospital, and as physician co
ordinator for the VA's national
hypertension program.

He is currently directing
the St. Louis section of a 16
center national study called the
Systolic Hypertension in the
Elderly Program (SHEP). The
study is designed to learn
whether lowering systolic
blood pressure with drugs will
decrease heart attacks and
strokes. It also investigates
whether medication can favor
ably affect memory and mental
powers in people aged 60 and
older.
St. Louis researchers plan to
enroll at least 300 men and
women aged 60 and older with
isolated systol ic hypertension
by March 1987 More than 200
volunteers are participating in
the local study. More informa
tion about SHEP is available
through the SHEP office,
314-367-2547 
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amuel E. Logan, M.D.,
Ph. D., assistant profes
sor of plastic and recon
structive surgery, has received
a three-year grant of $150,000
from the Whitaker Foundation
to continue investigating the
complex anatomy of the wrist.
In the future, he hopes to eval
uate and design improved wrist
operations and possibly an
improved wrist prosthesis.
Logan's research is a collab
oration among a number of
investigators in the Division of
Plastic Surgery and Michael
Vannier, M.D., associate
professor of radiology.
Logan is assistant professor
of mechanical engineering at
Washington University School
of Engineering and Applied
Science. _
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he School of Medicine
b i d ~ farewell to Jack
Siefkas, director of
medical development programs,
and welcomes hb replacement.
Mark W Bates.
Sicfkas, who served a~ di 
rector of medical alunUli ami
development programs ibr four
years, will be doing develop
ment work at the niversityof
Kansas for a Chic ago-ba~ed
consulting fi rm.
Bates comes to the School of
Medicine from the OUice of
University Relations at the Hill
top Campus. where he served
as assisttUlt vice chancellor and
directur of )pedal tkvdupmenl
programs. Batc~ came to the
uni versity in 1985 with nearly
27 years of institution(ll ad
vanccment experience in
Chicago, having served as
vice president and exccut ive
~ec retar} to the board of trust
ees at Iliinoi ~ Institu te of Tech
nology. and executive vice
president of the American
Fund lor Dental Ilealth.
A jollmalism gradlJ<lte from
orthwestem University, Bates
ha. also served as vice
president for institutiona l
advancement at the allege of
Sl. Franci s in Joliet, and vice
president for a developmcnt
consulting firm whose cl ients
included the Chicago Sym
phony Orch stra . •
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Nicholas T. KoucilOlikos, M.D, use~'llll alltotrallsfllsioll system he
designed to re-illtrodllce a patient's OWII blood after open-heart
surgery.

Blood Bt-eye!
. ill~'.
ccycling a patient's
own blooo during and
after open-heart ~l1rgery C<lIl, in some ca"c". l.!Onl
plctely eliminate the need for
donor blood
In a recent study ot' this
method conducted by il.!holus
T. Kouchoukos, M.D.. John M.
Schoenberg Profes!>or of
Card iovascular Surgery. allLl
Wi lliam G. Marshall Jr.. M.D..
a<;siSlant professor at "urgel·Y.
32 percent of 115 coronary
artery bypass graft patients
necded no donor blood .
Among those under the age of
70. 38 percent recei ved no
donor hlood .
··This auto-transfUSion sys
tcm has proven to be sate.
econom ical and ~imple to usc
and results in the s aving~ of
substantial amounts of red
blood cells and platelet),."
Kouchoukos says.
The auto-transfu sion system
lflvolves a fairly simple appara
tus that collects and ti lters
blood 10. t as che. t drainage
early after ~urgery That hlood
i ~ gradually reintroduced III the
pat ient\; body through all infu

siun pump during the flr~t IK
hours after surgl!ry. salvaging
an average of lInce un i L~ of red
blood cclb. To date. auto
tram.ru~ion has not been found
to be a~so~: iated with any sig
nificant complications, <;uch m.
in fection or hkcding requiring
fe-operation.
" Because of concerns from
both potential blood donors
and potent ial recirient~ con
cerning AJDs. as well as hepa
tit is and other disorde~ thaL
can be transmitted by blood
transfusions, an auto-transfu
sion svstem that can minimize
the usc of donor blood has
additional relevance."
Kmlchouko. adds.
"Whik: the risk of contract
ing one of lhe-.c dborLler:, is
extremely low. these anxieties
have placed pressure on the
blood supply and an under
stamlahle reticence among
some patienb to accept donor
blnod . We cannol guarantee
Lhat no donor blond will be
used. but we know that
elirr llnatinL! or minimiZing its
use has p{)~itive dTt:cts both on
the bl loo supply and on patient
morale. and docs reduce the
risk of contr.lcting any of (hc.se
disea..es.··

uuth who hegin u~ing
dnIgs before age 15 are
more likely to develop
severe drug abuse or depen
dence than those who postpone
dnIg use lI nlil a later age,
according \0 a study by inter
nationally recognized drug
abu'ic expert Lt:e N. Robi n~.
Ph .D.. professor of sociology
in psychiatry.
According to her study, or
all the participants who used
drugs five times or more, 25
percent of men and In percent
of women developed a drug
disorder (abuse or depen
dence). When usc began before
the a!!e of 15. however. the
figur~s more than doubled: 51
percent of the men and 39 (Jl!r
cent of lhe women developed
drug Llisorders. A., hTht Llrug
use wa... delayed, the risk of
developing a drug disorder
decreased. lIle study showed.
"We don't know yd why
carly usc of dnIgs is so danger
ous, but one n:ason may be
that it makes kids drop ()ut of'
school." Robins suggests.
" With no skill~, they have no
way of re-entering society
when they give up drugs, as
many will by their early 20s.
Thl: problem is how to prevent
other~ from starti ng drugs
without irreparably Llamaging
the kid, already involved
with drugs."
Not only is under 15 the
mt), t dangemus age for onet
of drug Ll~e, it also i ~ lIle ea ~i esl
time to intervene. Robins 'iay....
"One of the advantage~ of
working with younger kids i~
that it is easier to monitor their
behavior. Prohibit ing kids from
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leaving school at lunch is more
acccptabk to a 12- to 13-year
old than to a 17-year-old. The
re ·t fictions are more readily
accepted by younger kid~ .
8 L:ause the law says children
have to stay in school until they
are 16, it is much safer to con
front younger kids; older kids
may just dr)p out rather than
accept the :>trict new rule~. "
Her stUlly, "Age of Onset of
Drug Use a~ a Factor in Drug
and Other Di ~orders," co
authored with Thomas R.
Przybeck , Ph.D., a statisliL:al
data analysl, was pn.:pared fo r
the auonal In litute of Drug
Abuse. h was published by
the Department of Health an j
Human Servi es in "Etiology
ot Drug Abuse: Il1lplicntions
il1f Prevcntion."
Robins' ~ludy involved per
sonal i ntcrview~ with partici 
pant, aged IR 10 35 in ew
Haven , onn .: Baltimore: and
51. Lo u i~ . Respondents were
interviewed first between 1979
and 1981 and reinterviewed
a year later.
The study show,> that sex ,
race and education arc on ly
weakly related to drug disor
ders, wi th slightly higher ratc~
{or males, whites and i.nner-city
residents. Beginning dr ug use
before age 15 predicted an in
creased risk of drug di. order..
particul arly of a severe type.
Early onset ot use wa!'> also a5
sociatcu with more alcoholism
and antiSOCial personality in
later life.
The researchers looked for
factors that coulll predict drug
use. "Early ochavior prohkms
are very good predictor:, of
substance abu e." Robins
says. "although many drug
abusers are apparently norma l
children."

The leading predictors of
on. et of drug use are: early
drunkcnnes~, school discipline
problems. depre~~i()n. stealing,
vandalism <Inu truam:y. the
'itudy shows. Broken home~
al. 0 predicted drug abuse, but
were much less important that
the child ' own beha lor
Robins has a new grant from
the Na! ional lnstitute of Drug
Abuse and the ationa! In 'ti
lute ( f MCI1tal JleaIth to study
...... hether drug abuse by normal
youth differs in character and
consequence~ from ab u ~c by
those with a 1roubled beh:w ior
history. " Becau~e only 50
perct:n l of the dnlg lI ~ers hat.!
earlier Ix!havjor prohlems, we
want to know what the path
ways are to drugs for kids who
do not bav behavior prob
lems." Robins ~ay~ . 

.

Can('el" SU('if' f,

Elt'('(:-. L(WI.
irgil Loeb Jr. M.D '44,
professor of cllmcal
medic ine. has been
elected President of thc Amc ri
can Cancer Society.
Loeb su cc ~eus Chnrles A .
LeMail>tre, M.D. , of Houston,
who served tiS the Society's
Pre~ide l1 t for the ll}gS-86 tCnll.
During his tenure as presi
dent. Loeb plans to stress a
message of hope concerning
cancer. "Half of all cancer pa
tienb today are being cured, "
he ~ay~. "We have made
r~mar able progres\ uuring re
'en! decades in detecting and
treating cancer and in the
under~tanding of the biology
of I:ancer <I, wel l. Evidence
~e ms to int.! iL:ate thal we have
even greater prospect to pre 

the Board of cientific Coun
selors of the Division of ancer
Prev ntion and Control of the
ational Cancer Institute and
of the Institute of Medici ne of
lhe National Academy of
Sciences, Loeb has also served
on numerous commiltees of
the American ancer Society
and other organilati( ns. He
joined the National Board of
Directors of the Socicty in
1979, and is a former president
of both the ACS Missouri Di
vision Board and the SI. Loui s
nit Board.
His professio nal member
sh ips include the American
Board of Internal Med ici ne.
the American College of Physi
cians, the American Associa
lion tor Cancer Research and
the American Societ of Clini
cal Oncology.
A nati ve of St. Louis, Dr.
Loeb is married to the fom1er
Lenore Harlow. T hey have two
daughters and two sons. 
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vent cancer by maki ng careful
in our lifestyles. For
example, by choosing wisely
what we cat and choosing not
tl) smoke, we R'li ul'c our risk
of cancer considerably.
"We in the American Cancer
SOCIety cal l such choices 'lhk
ing Control,' and we have de
signed a program by that name
to guide pel)ple in making
value wi5c decisions relating to
cancer rish.. Urging Americans
to take control ol their lives by
making educated choices in
cancer detection. trealment and
prevention will be (lur ml:S 'age
Juring the year to come."
After receiving his M.D. .
Loeb ' on pleted internships, a
kllow hip and residency at
hospitals in Missollfi and Con
necticut and a traineeship ith
the National Canc r Institute,
returning to the university in
1950 a-; a Damon Runyon Re
,earch Fellow in Hematology
Currently :l member of
choice~

Virgil Loeb Jr., M.D., talks with his pa/im/ and cousin, Fay
Barker, in Mallinckrodt Institllte ofRadiology's Cancer Illfonlla
liull eel/let;
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Glutamate As
TRANSM TIER
AND

TOXIN
R Y I' ,\ t ' I

t happens in Alzheimer 's disease,
Huntington's chorea , epilepsy and other
well known neurobiological disorders. It
happens in cerebral palsy, cardiac arrest,
stroke, hypoglycemia and other cases where
the brain's supply of precious oxygen or
glucose is interrupted. It happens in head
injuries from football games, stai rway
tumbles and auto accidents.
Nerve cells in the brain die and are not
replenished - the brain is damaged.
But two decades of research by John W
Olney, professor of psychiatry and neuro
pathology, have brought us closer to under
standing the mysterious causes for such
brain damage, and accumulating evidence
suggests that novel drugs may soon be in
the kits of physicians, even paramedics, to
prevent nerve cells from dying in at least
some of these conditions.
This is not a story of a medical break
through. There were no flashes of light, no
cries of "Eureka l " It was more ofa medical
"wearthrough," a tedious trek towards a
new understanding of neuropathological
processes that began in 1968.
Prior to that time, a common amino acid
called glutamate (Glu), which is found in
high concentration in brain, had been
shown to have an excitatory effect on cen
tral neurons. Paradox ica lly, this same
substance also was found to cause the
degeneration of nerve cells in the immature
retina of baby mice, when injected under
the sk in.
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As a resident at Washington University
School of Medicine in the late 1960s, Olney
confirmed Glu 's damaging effects on imma
ture mouse retina using both light and
electron microscopy. Then he found that
treatment of mice with Glu in infancy
caused them to have a grossly abnormal
body constitution as they grew to adulthood
- they became obese, short and often
sterile, By 1969 he had traced the cause of
these developmental abnormalities to a toxic
action of Glu on nerve cells in the hypo
thalamus, a brain region that exerts regula
tory control over growth and development.
At this point he knew that he was in hot
pursuit of something very intriguing: [f Glu
occurs naturally in high concentrations
throughout the central nervous sys tem ,
how can it also be a toxin that can kill
nerve cells?
In the ensuing decade, Glu became
recognized as an exceedingly important
substance in the brain, Not only is it a major
building block in the formation of important
brain peptides and proteins, but it also is
a neurotransmitter that excites ce ntral
neurons, thereby mediating information
transfer from one cell to another. Indeed, it
is currently believed to be the neurotrans
mitter released at the majority of excitatory
synapses in the central nervous system.
Recognition of Glu as mediator of vitally
important functions in brain made the
enigma confronting Olney all the more

challenging. The paradox: A substance
integral to the brain's information proces
sing functions has the potential of killing
brain cells.
Major progress in unraveling the mystery
was ac hieved by studying a large number of
Glu analogs. Prominent Australian elec
trophysiologists, David Curtis and J.c.
Watkins, found that some Glu analog ' re
produce the neuroexcitatory effects of G lu,
and some do not. In 1970, Olney demon
strated that the same Glu analogs that repro
duce the excitatory effects of Glu also
reproduce its neurotoxic effects. This basic
observation has been confirmed repeatedly.
Thus, the excitatory mechani sm by which
Glu passes messages from one cell to
another is believed to be the same mecha
nism by which it kills nerve cells. "Glu
might be viewed as a Jekyll and Hyde
molecule," Olney says. "W hen present in
side the nerve cell in normal concentrations,
it is a benign substance that plays exceed
ingly important roles in brain physiology ;
if released from the nerve cell and not
immediately taken back up, it interacts per
sistently with excitatory receptors on the
external surface of the nerve cell and , in
essence, excites the cell to death. " To
describe this unique duality, Olney coined
the term "excitotoxin ," a term which is now
in common use among neuroscienti sts.
The most immediate impact of this dis
covery was its research applications. Before
Olney's contribution, researchers studying
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brain function used a method that seems
quite crude by today's standards. A wire
was inserted into the brain of an anes
thetized animal, and a given area of the
brain was destroyed when electric current
was passed through the wire. Any loss of
function or change in behavior was tenta
tively attributed to the cells destroyed.
"The trouble with this method," Olney
says, "is that it destroys everything in the
area, including fibrous tracts that inter
connect other brain regions. Sure, you can
observe loss of function, but you cannot
confidently attribute it to loss of the
targeted cells; it might reflect the fact that
fibers interconnecting other cells have been
severed." Excitotoxins act at excitatory
receptors on the surface of the target nerve
cell, but fibers of passage are not damaged
because they do not have such receptors.
Olney 's research has resulted in the identifi
cation of numerous excitotoxic analogs of
Glu that are much more powerful than Glu
and interact selectively with specific Glu
receptor SUbtypes. "By carefully choosing
the Glu analog that matches the receptors
on the cell types targeted, researchers can
destroy nerve cells with greater selectivity,"
says Madelon T. Price, Ph.D., research
assistant professor of neurobiology in
psychiatry, who joined Olney's research
team in 1974.
The excitotoxin approach provides more
reliable results than could be obtained with
the old electric current method . "It's a sort
of chemo-surgery," says Olney, "that allows
one to draw more specific conclusions
with regard to which nerve cells are respon
sible for which functions."
The most dramatic impact of excitotoxin
research is its potential clinical applications.
In the early 1970s, Olney expressed the view
that, given Glu's ubiquity in brain and strik
ing neurotoxic potential , it would be sur
prising if Glu irregularity wasn't implicated
by neurodegenerative diseases. "In fact,
over the past five years researchers from all
over the world have been reporting new evi
dence potentially linking the excitotoxic
action of Glu to brain damage associated
with epilepsy, stroke, cerebral palsy, Hun
tington's chorea, Alzheimer'S disease and
several other less well known neurological
conditions," Olney says. "On the basis of
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very recent evidence, it has even been pro
posed that a defect in the Glu transmitter
system might playa role in schizophrenia."
"We suspected early on that clinical ap
plications would be found ," Price says. "But
the number of potential clinical applications
turning up is rather bewildering."
Between nerve impulses the Glu is stored
safely inside cells. During the transmission

Some Glu afUllogs cause more damage to
nerve cells than others. A serres ofthree
micrographs showsfrom top to bottom: un
damaged retifUl, partwl damage to retifUl
from one Glu afIillog and extensive retinal
damage from yet another Glu afUllog.

of a nerve signal, it is released from the cell
in tiny amounts for a fractiG ~ of a second,
then immediately taken back up so the ex
citatory receptors will not be excessively
stimulated. The mechanisms responsible for
gathering up Glu after it has performed its
message-carrying function and returning it
to the cell's interior are normally very
efficient. However, under abnormal circum
stances - for example, when the brain's
supply of blood, oxygen or sugar is deficient
- these mechanisms fail , and Glu begins
to accumulate outside the cell. Breakdown
of the delicate mechanisms that hold Glu in
check can lead to a rush of excitotoxin - a
glutamate tsunami - which floods numer
ous receptors with brain poison.
The role of Glu in the neuropathology of
head trauma is not well understood, but
there is basis for suspecting that physical
trauma, such as an auto accident or even
neurosurgical procedures, can cause a re
lease of Glu from its storage compartments
inside the cell. Glu has several "metabolic"
functions in add ition to its transmitter
function. A common amino acid, it is
ubiquitous as a component of proteins.
Every brain cell contains much larger
amounts of Glu than are necessary for
transmitter purposes. It is thought that brain
trauma results ;n the release of Glu from
metabolic as well as transmitter storage
compartments and, because receptors do
not distinguish between metabolic and
transmitter Glu, they are over-stimulated
by excesses of either.
"If we could find a way to block Glu
receptors," Price says, "we might be able to
protect those cells from being killed and
prevent a lot of brain damage. "
According to Olney, it is not unreali stic
to believe that Glu receptor antagonists will
one day be used successfully to prevent
brain damage from stroke.
Steven Rothman, M.D., assistant profes
sor of pediatrics and neurology at Washing
ton University, has contributed valuable
evidence on this point. When nerve cells
grown in culture are deprived of oxygen ,
they rapidly die; but Dr. Rothman has
shown that they can be protected from
death by adding a Glu receptor antagonist
to the culture medium. Swedish inves
tigators have shown that when the blood
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sing a Glu analog to selectively
. destroy nerve cell groups known to
be damaged in Alzheimer's disease,
Olney and his colleagues have created an
animal model of the disease's effects
on memory.
In the behavioral lab at Shriner's
Hospital, David Wozniak, Ph.D., research
associate in psychiatry, tests the memory
capacities of rats using a radial arm maze.
When he places a rat in the center of
the maze, it is free to run down any of
eight alleys, each leading to a chocolate
chip. Once the rat has selected an alley,
Wozniak uses string pulleys to close
the trap doors to the other seven alleys;
the remaining trap door is closed after
the rat has returned to the center. After
five seconds, the trap doors are re-opened
and the process begins anew.
As it h..s already eaten the chocolate
chips in the traveled alleys, the rat must
enter a new alley to obtain its "chocolate
fix." Wozniak observes how much time
it takes for normal and brain-altered

J

rats to remember and make eight "cor
rect" alley choices out of nine.
Preliminary results have shown that
it takes rats with analog-induced
Alzheimer-like lesions considerably

longer to achieve this criterion than it
does normal rats, indicating the powerful
and debilitating effects the lesions have
on memory. •
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supply is cut off to certain portions of an
animal's brain, there is an outpouring of
Glu from brain cells. In the absence of oxy
gen, the mechanism responsible for taking
Glu back into the cell stops working. Thus,
Glu remains in contact with receptors for
a prolonged period, and cells are destroyed.
It has been shown in this type of animal
model that cell death can be prevented by
injecting a Glu receptor antagonist directly
into vulnerable brain regions.
A major problem, until very recently, has
been the fact that none of the known Glu
receptor antagonists passes readily across
blood brain barriers. However, Olney's re
search team recently identified agents that
effectively block Glu neurotoxicity and can
pass from the blood into brain. "We have
found that such agents prevent brain dam
age associated with prolonged seizures,"
says Olney, "and 1 am optimistic that they
will prove effective in preventing other
forms of brain damage."
A special problem in preventing brain
damage associated with stroke is that you
can't get the receptor blocker to the part
of the brain undergoing damage because
the blood vessel feeding that brain region
is plugged with a clot. With the use of
new drugs that can quickly dissolve such

clots, Olney believes that one of the first
clinical applications of excitotoxin research
may be in the management of stroke. "I can
easily envision treating stroke patients
with a combination of a blood clot dissolver
and a Glu blocker," he says, "a sort of
brain-saving cocktail."
Olney 'S team is also interested in apply
ing Glu blocking agents to prevent brain
damage associated with respiratory failure
in newborns. Emergency measures usually
restore spontaneous breathing, but lack of
oxygen during the period of respiratory fail
ure, even if relatively brief, can give rise
to cerebral palsy. The prime suspect: cell
damage caused by an accumulation of Glu
at excitatory receptors. "If a Glu blocker
were used at the first sign of trouble," Price
says, "it may be possible to prevent that
brain damage."
One of the most potent GJu blockers
Olney has identified is phencyclidine (PCP),
a psychedelic drug otherwise known as
angel dust. Olney's team has shown that this
ordinarily devastating drug and related
agents powerfully protect nerve cells
against the toxic action of Glu and also pre
vent brain damage of the type caused by
seizures. Present evidence suggests that

these agents also protect nerve cells from
dying when the blood supply to the brain
has been cut off. Thus, angel dust or related
drugs may assume a new image one day as
protectors of human health.
And, as angel dust is not only a powerful
blocker of Glu receptors but produces, in
normal individuals, two common manifes
tations of schizophrenia - hallucinations
and delusions - Olney and his colleagues
are becoming fascinated with the possibility
that dysfunction of the Glu transmitter
system might playa role in schizophrenia.
The list goes on . There is speculation
implicating an excitotoxic mechanism in
Huntington's chorea and Alzheimer'S
disease, both of which involve the death of
specific nerve cells. Olney considers this
relatively unlikely but he says, "Ten years
ago, I could not have predicted that we
would find an excitotoxin link to the brain
damage associated with epilepsy, stroke,
perinatal asphyxia or cardiac arrest." Re
searchers around the world are carefully
studying the potential implications of recent
findings .; I this new field of excitotoxicology
- a field that can truly be considered
Olney's brainchild , born and raised in his
psychiatry laboratories at Washington
University School of Medicine.
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Like many short children, Justin was
average size at birth, weighing 7 pounds 8
ounces. Though he was a small toddle" that
seemed quite normal because hi s mother is
5 feet 4 inches, and his father 5 feet 7 inches.
Only when he reached the age of 4 did
anyone notice a problem . Just before Justin
entered kindergarten, the specialist who
measured him for orthopedic shoes dis
covered that Justin's feet hadn't grown at
all in the last year and a hal f.
About 2.5 percent of all children fall
below the normal height range for their age
- that's over 1.75 million kids in the United
States alone. Those with abnormal propor
tions tend to have chromosomal defects or
bone disorders, whereas children who
are simply short may have kidney disease,
gastrointestinal disorders or endocrine
problems.
Short children like Ju stin, who have
endocrine disorders, are the target of a new
study at the School of Medicine that began
last spring and will continue until 1990.
Headed by Dennis Bier, M.D., professor of
pediatrics and co-director of the Divi sion of
Endocrinology and Metabolism at Chil
dren's Hospital, the study aims to identify
new causes of growth failure . It will also
see which types of patients can respond
to growth hormone, a protein that triggers
growth.
Growth hormone has been used to treat
short children for the past 25 years. The
School of Medicine was one of the first
institutions to use this therapy, but until re
cently the hormone had to be purified from
the pea-si7.:d pituitary glands of cadavers
and was therefore in very short supply.
When Justin Leib sought treatment else
where in 1979, he was refused the hormone
because he did not meet the strict criteria
for its distribution. But on Washington's
Birthday in 1983, he obtained treatment at
Washington University by taking part in a
clinical trial of human growth hormone
made through recombinant DNA technology.
The recombinant hormone was approved
by the FDA in October 1985, after the natu
ral hormone was banned for further clinical
use because in rare instances it seemed to
be linked to a dementing neurological dis
ease called Jakob-Creutzfeldt syndrome.
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e have a lot of
hypotheses, but we don't know
----- -whether individuals will
respond unless we put our
ideas into practice."
This normally rare condition is caused by
a virus that infects the brain, so it could
be transmitted by contaminated human
pituitary tissue extracts.
When Justin started his growth hormone
injections at the age of 81/2, he was only
431/2 inches taJl - the height of an average
6-year-old. His response was immediate,
and he began to grow an astonishing inch
every two months as he started to catch up
in height. "There was a time when he grew
out of a pair of tennis shoes every six
weeks," his mother recalls happily. "And
last year, after we had a major fire at our
house, we were given lots of gifts from
friend s. One was an expensive pair of jeans
for Justin , which I saved for a trip to Disney
World. But when we got there three weeks
later, he couldn't get into them, and I had to
go buy him another pair."
The boy who once heard his mother's
friend describe him as " the little guy who's
no bigger than a bar of soap" is now 58
inches ta1l - just over the average height
for his 111/2 years. When his family recently
moved to a new town , and his mother Kathy
had to explain why he was having shots,
her new friends found it hard to believe that
he had ever had a growth problem.
At present, the FDA sanctions growth
hormone therapy only for children like
Justin, with growth hormone deficiency.
"But most of us feel that there are many
other children who will respond to treat
ment, though this has not been clearly es
tablished," says William Daughaday, M.D.,
the Irene E. and Michael M. Karl Professor

in Metabolism. " For example, there may be
patients who are partially growth hormone
deficient who may respond to higher doses
than we were able to obtain in the past. "
Widening the scope of growth hormone
therapy isn't the only aim of the study; how
ever, another goal is to identify defects other
than growth hormone shortage that lead to
short stature. "Five or six years ago, we re
alized that methods for evaluating growth
deficiencies were not adequate," Bier says.
"For example, many children that were
diagnosed as growth-hormone deficient
were not really lacking in the hormone. In
stead, they were unable to release the hor
mone from the pituitary."
Only 10 percent of short children who
come to the endocrine clinic because of
their size have problems that can be rou
tinely diagnosed. "The other 90 percent are
the ones we are particularly interested in,
regarding the mechanism of growth impair
ment ," Daughaday says. "One of our major
interests is in recogni zing individuals who
put out abnormal growth hormone or ab
normal somatomedin, a growth-promoting
protein that is made in the body in response
to growth hormone."
The study will include about 50 of the
300 to 400 short children who are referred
to Children's Hospital each year from
southern Illinois and eastern Missouri. Dur
ing a child 's first visit, a team of pediatric
endocrinologists consisting of Bier, Sherida
Tollefsen, M.D., assistant professor of pedi
atrics, and David Dempsher, M.D., fellow
in pediatric endocrinology, will take a medi
cal history to screen out children who are
not abnormally short, or whose growth
deficiency is due to causes other than an
endocrine disorder.
After screening, children who qualify for
the study spend three days in Children's
Hospital, where their ability to secrete
growth hormone is measured with routine
clinical tests. They also donate blood sam
ples and a pinhead-sized patch of skin for
new growth tests, which have been devel
oped at Washington University. Over the
next several weeks or months these samples
are studied, and the children visit the hospi
tal regularly to be accurately measured.
When the results of the tests are avail
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James Gavin Ill, M.D., uses radioimmurwassay techniques to detennine iruiividuoJ
paJients' abilities to secrete growth IUJrlrwtle.
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able, and growth rates are established, chil
dren come back to the hospital for another
seven days. This time, rate of protein
synthesis and breakdown is measured
before and after a couple of days of growth
hormone treatment. Since protein accretion
is an essential component for the deposition
of new tissues, these tests assess children's
current capacity for growth.
Before leaving the hospital this second
time, children begin thrice-weekly injec
tions of growth hormone, which continue
for six months - long enough to see even
belated responses. If growth-rate increases
by at least half an inch during this period,
the child stays in the program and receives a
further six months' supply of the honnone,
Treating a 10- to l5-year-old child with
growth hormone for one year costs $10,000
to $20,000, and that money comes from the
$2-million grant awarded for the study by
the National Institute of Child Health and
Human Development.
Awareness that short stature can have
many different causes came after scientists
began to unravel the complex cascade of
events that controls growth. When Daugha
day came to the School of Medicine in the
1940s, it was thought that growth hormone
acted directly on tissues to promote the syn

thesis of new materials, such as cartilage,
that build the human body So Daughaday
tried to assay the hormone by determining
in vitro its effect on the uptake of sulfate
ions into cartilage - a measure of growth,
fnstead, he discovered that growth hormone
has absolutely no effect on cartilage forma
tion outside the human body
By 1957, Daughaday discovered the
reason for this anomaly He found that
serum from normal rats could stimulate sul
fate intake, but the serum from rats whose
pituitaries had been removed could not.
This led him to the conclusion that serum
normally contains a growth-promoting sub
stance he called sulfation factor that is
induced by growth hormone, This and other
related proteins are now known as somato
medins becase they act as mediators be
tween growth hormone and growing tissues.
The current hypothesis is that growth
hormone does not directly stimulate growth,
but rather acts through the intermediary
protein somatomedin, which in turn triggers
cells to increase their synthesis of proteins
and other substances essential for growth.
When growth hormone that has been re
leased into the bloodstream by the pituitary
reaches certain cells, it plugs into growth
hormone receptors on their outer mem
branes, signaling them to produce somato

medin . This intermediary protein is released
from these cells and binds to somatomedin
receptors on other cells targeted for growth.
The binding of somatomedin to these cells
stimulates them to produce proteins and
other substances essential for growth.
This dual-control system, involving both
growth hormone and somatomedin, seems
to have many advantages over a system
involving growth hormone alone, but it also
provides more scope for error. Thus short
stature could theoretically be due not only
to errors in the production or secretion of
growth hormone, but also to the synthesis
of a biologically inactive growth honnone
that can't bind to growth hormone recep
tors, Deficiencies or defects in those recep
tors or in somatomedin could also stunt
growth, as could too few or defective
somatomedin receptors,
These hypotheses evolved from studies
with animals and cultured human cell lines,
The Washington University study will see
how they hold up during clinical testjng,
when defects identified in children by
laboratory tests will be correlated with re
sponse - or lack of response - to therapy
For example, a child with defective
somatomedin shouldn't respond to growth
hormone if control of growth has been
interpreted correctly
"We have a lot of hypotheses," Daughaday
says, "but we don't know whether individu
als will respond unless we put our tests into
practice. We need to know if our criteria
for predicting a growth defect are accurate
enough, "
The unique aspect of this study is that it
brings together five principal investigators
whose combined research covers every link
in the chain of events between growth
hormone secretion from the pituitary and
protein synthesis in tissues.
James Gavin III, MD., associate pro
fessor of medicine, focuses on the events
between growth honnone secretion and
somatomec:'" synthesis, He measures the
amount of growth hormone a child can
secrete by adding a sample of the child's
serum to radioactive growth hormone com
bined with an antibody Since each antibody
molecule can combine with only one
growth honnone molecule, some of the
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radiolabeled molecules are displaced if
there is growth hormone in the serum. The
concentration of the latter can be calculated
from the amount of radioactivity that re
mains bound. The principle is similar to a
game of musical chairs. If five people are
playing the game with five chairs, each will
be able to sit down. But if an extra 20 peo
ple suddenly gatecrash the party, the chance
of one of the original players getting a chair
falls to one in five. One could calculate the
number of gatecrashers from the number of
original guests that manage to sit down.
Although this standard radioimmunoas
say measures the quantity of growth hor
mone, it reveals nothing about its biological
activity because the part of the growth hor
mone molecule that binds to an antibody is
different from the part that binds to the
growth hormone receptor. Yet Gavin has
learned how to use the same principle to
assay biological activity, using different
"players" and different "chairs" with a cul
tured human ceJl line as a source of growth
hormone that can compete with radioactive
growth hormone already bound to the
ceJl surface. If the growth hormone in the
serum cannol bind to the receptors, Gavin
deduces that it has an abnormal structure.
To assay the receptor itself, Gavin hopes
to compare the binding of radioactive
growth hormone to fibroblasts from a ceJl
bank with tha. to fibroblasts grown from
skin sample~ of the short children in the
study. So far, he has perfected the technique
for animal celis, and within the next few
months he hopes to determine the optimal
conditions for measuring human growth
hormone receptors.
The next link in the chain is somatomedin
synthesis, for this protein is the net result of
the binding of growth hormone to its recep
tor. After incubating a child's fibroblasts
with growth hormone, Gavin measures
the quantity and activity of the resulting
somatomedin with a radioimmunoassay and
a biological assay.
The Washington University team is also
studying somatomedin synthesis at its most
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hen Justin started his
growth honnone injections at
the age of 8V2, he was only
43V2 inches tall- the height
of an average 6-year-old.
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basic level - by looking at the gene that
codes for the protein. Peter Rotwein, M.D.,
assistant professor of medicine, finished
sequencing the normal somatomedin gene
last year. Now he will look at the gene in
children with seemingly abnormal somato
medin, obtaining the necessary DNA from
their white blood cells. "The assay of
somatomedin per se is step one - kind of a
best guess that this one might be abnor
mal," he says. "So we are going to take it
from there and try to confirm that the pro
tein is coded for by an abnormal gene. Then
we'll try to show that the abnormal gene is
the problem in that particular individual's
failure to grow."
Rotwein will also alter the gene in cul
tured cells and look at the effect on somato
medin production and activity. He hopes to
study the regulation of somatomedin syn
thesis as well, asking how the binding of
growth hormone to its receptor switches on
somatomedin production.
The final link in the chain - the soma
tomedin receptor - is assayed in animal
cells by Gavin in much the same way as the
growth hormone receptor, but with radio
labeled somatomedin in place of growth
hormone. Using an alternative approach in
human cells, Daughaday measures the up
take of radioactive amino acid analogs into
fibroblasts that he stimulates with commer
cial somatomedin. Since amino acid uptake
is one of several events that somatomedin
binding switches on , its rate reflects the
number of receptors on the cell surface
and important post-receptor mechanisms
related to cell growth.
Tollefsen studies the structure and syn

thesis of the somatomedin receptor, trying
to develop methods that eventually will
pinpoint precise defects She just achieved
the first purification of the receptor, which
consists of four polypeptide subunits - two
alpha and two beta - plus an undetermined
number of side chains built of sugars.
ToLlefsen's current goal is to study the bio
synthesis of the receptor in cultured fibro
blasts, looking at the complex processing of
its precursors. Once she has uncovered the
normal sequence of events, she wi II look for
abnormalities in children with short stature.
The study of protein synthesis - the
business end of the growth process - is the
province of Bier and Dempsher, and is a
natural outcome of Bier's 13-year interest
in the effects of hormones, nutrition and
disease on human metabolism. As no single
test can tell if a child's protein metabolism
is normal, the researchers do several assays.
On the one hand, they look at the incorpo
ration of amino acids from food into pro
teins in the bloodstream. On the other hand,
they measure the wastage of these amino
acids as their atoms are excreted in carbon
dioxide in breath and urea in urine. The
radioactive labels that are used in the labo
ratory tests would be harmful to children,
so they label the amino acids with harmless
stable isotopes that can be detected by their
slightly different mass.
By bringing together this wide range of
expertise in clinical medicine and basic
biology, the researchers aim to diagnose any
defect in the growth-controlling sequence
Such a study is essential to further progress,
for physicians must be able to detect the
cause of a growth defiCiency before they
can plan rational therapy. The researchers
are hopeful their labors will open the way
to new treatments, such as injections with
recombinant somatomedin for children with
defective growth hormone receptors or
somatomedin genes. Then, like Justin Leib,
more children will be able to outgrow their
growth deficiencies.
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f this were any other virus, this would be the perfect
vaccine. It replicates, but doesn't kill. It's an attenuated virus just
like everyone gets vaccinated with for polio."
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By sLicing into the DNA ofthe
IfTLV-1I1 virus, Lee Ratner has
created two mutants that do not
kill hwnan immune cells. but
may serve as weapons against
the originalform.

L

ike a night watchman on his appointed
rounds, an ever-vigilant helper T
cell patrols a vessel of the lower
genital tract.
This circulating sentinel detects a foreign
antigen in a nearby capillary bed , determin
ing the invader to be a white blood cell of
similar cell type. But as the two T cells
meet, the AIDS virus that was hiding in the
invading cell slips through the cell mem
branes into the defending cell before that
cell can sound the alann.
Once inside the inactive helper T cell, the
subversive AlCS ' irus decodes genetic in
formation from it~ RNA core into a DNA
form that is recognized by the T cell as its
own and inserted into its chromosomes.
There it may I ie dormant for weeks,
months, even years until some other infec
tion triggers the invaded cell to divide. The
viral DNA then reprograms a key com
ponent of the T cell's genetic machinery, so
that the cell churns out copies of the virus
faster than it can manufac ture its own
cell parts.
One by one, these viral clones bud from
the cell to infect neighboring T cells. And
after enough copies of the virus have been

produced, the ungrateful AIDS virus kills
its host cell. By killing these critical lym
phocytes, the AIDS virus short-circuits the
entire immune system. Without enough
helper T cells to signal the attack, the other
soldiers of the immune system - phago
cytes, killer cells and B cells - are never
called into action, leaving the body wide
open to a constant assault of secondary
infections that include cancer, herpes, in
flammations of the lung and brain, fungal
infections and prolonged diarrhea.
The human immune system is no match
for the rapidly spreading AIDS virus, as
evidenced by the fact that half of the mOre
than 23,000 Americans who have been
diagnosed with AIDS are already dead. But
while the AIDS virus easily defeats the
body's first line of defense (the immune sys
tem), this viru s has yet to receive the brunt
of humanity 's surest defense - the mind.
Taking the lead in the mind 's war on the
microbe is Lee Ratner, M.D., Ph.D., assis
tant professor of medicine. Collaborating
with Robert C. Gallo, M.D. , from the Na
tional Cancer Institute and six other re-
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"T---------------------------------------
he problem with this class of viruses is that they get
converted into DNA forms, which go into your chromosomes and
stay there forever."

Lee Ratner, M.D., Ph.D.
searchers, Ratner has successfully cloned
two mutants of the AIDS VlIuS that may
eventually be used to beat the original form
at its own game.
The genetically aJtered viruses behave in
exactly the same way as the original AIDS
virus, except that they do not kill T cells.
Ratner and his colleagues, who recently
reported their unprecedented results in an
August 8 issue of Science, created disarmed
variants of the AIDS virus by slicing into
its genes.
Ratner and his fellow investigators
opened up circular strands of the virus'
DNA with a bacteriaJ enzyme that cuts
through the DNA at only one point on the
circle. Then they added a second enzyme
that chews inwards from both ends of the
DNA, as if it were removing beads from the
ends of an unclapsed necklace. fn this way,
they created holes of varying size along the
DNA strand. After ligating or "reclapsing"
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the ends, the investigators isolated six
genetic variants which, when added to cul
tured T cells, produced six correspondingly
mutated viruses.
The two non-lethal mutants were created
more or less by accident, according to
Ratner. They were fonned when the enzyme
chewed past the suspected killing gene into
the next gene, which really does control cell
killing. The four mutants that contained
alterations only in the originally suspected
killing gene retained their ability to kill,
ruling out that gene as the killing gene.
Because non-lethal mutants of the AIDS
virus replicate just like the killing form,
they may eventually be used to treat AIDS
patients in the hope that the non-lethal
forms might outcompete the killing variety
for helper T cells. Studies are already under
way to determine whether or not these
mutants can outcompete the killing virus
in cultured T cells. "If this were any other

virus, this would be the perfect vaccine,"
Ratner says. "It replicates, but doesn't kill.
It's an attenuated virus just like everyone
gets vaccinated with for polio."
Although mutants of the virus may be
used to help people who already have
AIDS, they wi II probably never be used as
a vaccine for non-infected patients. "The
problem with this class of viruses is that
they get converted into DNA forms, which
go into your chromosomes and stay there
forever," Ratner says. A live retrovirus will
probably never be of any use as a vaccine,
because it could damage normal genes.
"Whether it actually would or not, we don't
know," Ratner says. "But it's too dangerous
to take a chance."
Even more important than any clinical
role they may play, Ratner's mutants have
provided AIDS researchers with a powerful
new tool for learning exactly how the AIDS
virus kills the T cell.
"What we have is a mutant
virus and a wild type
virus -- both of which
grow well - and yet
one kills, and one
doesn't. Now
we'll be able to
separate out the
effects of

Dr. Ratner's AIDS
virus mutants invade
T cells in much the
same way as the orig
inal virus. Unlike the
original, Iwwever,
the mutants are not
kthaL to T cells. Cells
already occupied by
mutantforms may be
protectedfrom sub
sequent infection by
the deadly variety.
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virus replication alone from that of cell kill
ing, by comparing the effects of our killing
variety virus to our now-mutant virus,"
Ratner says.
More specificaJly, Ratner and his col
leagues are using the mutant viruslkilling
virus comparison to look for cellular pro
teins that might be involved in cell killing.
'There are a number of proteins - some
that we know about and probably some
that we don't know about - that are made
by lymphocytes and kill lymphocytes, "
Ratner says.
Ratner speculates that if researchers
could identify such a cellular protein, they
would eventually be able to engineer a drug
that interferes with the production of that
protein . "Our major goal is not to sort
through the chemistry shelf for drugs that
inhibit viral replication," he says. "Rather,
by learning what structures are involved
in killing lymphocytes, we'll have a way
to actually design drugs based on those
structures. "
A former research fellow under Gallo
at the NCI, Ratner has made several sub
stantial contributions to frontline AIDS
research . He was one of 19 individuals
responsible for initially cracking the virus'
genetic code, and one of the first research
ers to produce its biologically active
molecular clone.
Although he works so closely with the
virus, Ratner is not worried about catching
AIDS. "AU of the evidence suggests that the
way we work with the virus is very safe,"
he says. "Nobody who's ever worked in an
AIDS research lab has ever developed
antibodies to the virus."
In the long run, man's battle with AIDS
may actually serve to sharpen his mind for
the larger war against all microbes. "I think
we're going to get a lot of information about
virology in general from this, because there's
never been this kind of intense research on
one virus," Ratner says. "More has been
done in the last two years on this virus than
has been done in the last 40 years on the
polio virus. By studying one virus extremely
intensely, we're actually learning more
about the basic biology of all viruses." •
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His decision to resume his career in
surgery led him in 1936 to Washington Uni
versity School of Medicine, where he was
appointed a fellow in neurosurgery under
Ernest Sachs, M.D., who was chief of the
neurosurgical service and held the first aca
demic appointment as professor of neuro
surgery in the
United States.
Although his
original intention
was to stay just
one year, 50
years later
Schwartz is still
here.
Schwartz's
career at the
School of
Medicine has
been a distin
guished one.
The long-time
head of the
Department
of Neurologi
cal Surgery,
now August
A. Busch
Professor
Emeritus, is
one of the
mostes
teemed neurosurgeons in the world . He has
received every major honor from his col
leagues, who recognize him for his scholar's
mind, his numerous clinical contributions
and advances and particularly for building
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one of the great neurosurgery training programs: 14 of the 45 resi
dents Schwartz trained in his 28 years as department head have
gone on to direct their own training programs.
rom his residents, he demanded excellence. The almost
impossibly high standards he set for them, however, were
no higher than those he set for himself. Colleagues and
tormer residents alike describe him as a dedicated physician and
perfectionist in patient care.
"In his work habits, his day-to-day activity, there is a painful
attention to detail and an integrity that characterizes his practice of
medicine and his way of life," comments Sidney Goldring, M.D. ,
who trained under Schwartz in the early 1950s and succeeded him
as professor and head of the Department of Neurological Surgery.
Goldring has written of Schwartz, "He demanded exceJJence
from his men, and the rigors encountered by his residents in
meeting those demands have become legendary."
Schwartz describes himself as a "tough taskmaster." Of his
trainees he says, chuckling, "They'll probably call me all kinds of
names and then they'll probably say that they love me as much as I
love them."
Robert King, M.D., one of Schwartz's first residents,
laughingly admits that some people would describe Schwartz
as "more than tough . But there was never any question that
his concern was for your own development and for the pa
tient's good. And he was fair," King adds. After completing
his residency, King went on to become Schwartz's first faculty
appointee, leaving the medical center in 1957 to become head
of the neurosurgery program at Syracuse University. "The
likelihood is that I've translated into our program and into
my own life many things from him that I don't link directly
back to him. His indirect persuasions can be very, very
powerful."
In a 1974 address to the Congress of Neurological Surgeons,
Schwartz spoke of his almost paternal feelings toward his trainees,
quoting a colleague's words about family: " 'It is with our chil
dren that we have the unusual opportunity to help them attain
responsible adulthood and take their active place in society. .. .
They should know our love where love is not indulgence and giv
ing in, but is to a great degree discipline, where we care enough to
want them to grow up right.' "
He continued, "Better than any phrase I might devise, this
expresses my own feeling toward those young men whom good
fortune has sent to my program. I have demanded much of them
but have wanted much for them. Their successes have been my
reward and my job."
Residency under Schwartz was difficult, recalls William E
Collins, M.D., who also trained with him in the early 1950s and
now heads the department of surgery at Yale University Medical
Center.
"I got so upset when he was upset with me one time, 1 told him
... that 1 not only didn't have to be a neurosurgeon, I didn't even
have to be a doctor. I could be something else if he thought I was
that bad, but I wanted another opinion," Collins recounts. "His
reply to me was, 'Don't be foolish. I'll tell you when you're not
good enough to go on,' and he walked off. That," he laughs, "was
a compliment."
Today, Collins considers Schwartz a close personal and pro
fessional friend. "He has been probably more supportive of me
than almost anybody I know and has helped tremendously to
allow me to develop the two programs that I've set up." Accord
ing to Collins, one of Schwartz's very striking traits is his
generosity in helping his former residents iron out their prob
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lems, develop programs and decide which direction to go in
the profession.
Goldring agrees. "He puts a tremendous amount of emphasis
on loyalty and is extremely loyal to those he respects and
works with."
Schwartz's neurosurgery training program's success, many say,
is due in large part to his emphasis on research. The residency
program he set up in 1946 was one of the first in the country to set
aside a substantial block of time solely for research. Neurosur
geons trained by Schwartz, therefore, had an attribute that most
other residents lacked - a background in either basic or clinical
research on the nervous system.
As Collins points out, "They not only had a very careful
instruction in surgery - to the point that it was almost impossible
to please him completely - but at the same time, a very thorough
instruction in basic anatomy and basic pathology and then an
opportunity to use investigative techniques to study the nervous
system. That combination was extremely rare in any of the
neurosurgical programs at that time."
"He set extremely high standards for people going through that
program , so that he required not only to know what you should
do, but why you should do it. And that ... was a change .. .
recognized throughout the country, so that the major training pro
grams really started to foJlow his lead .
"He really was the pivotal point as to the change that occurred
from developing a person who was a technical surgeon to one who
was an academic neurosurgeon."
Schwartz himself takes a modest view. The values that
he tried to instill in his residents, he says, were those of the
greats of medicine: William Halsted, the Johns Hopkins sur
geon who trained numerous physicians and whose philosophy
dominates the profession even today; Evarts Graham , head
of surgery at Washington University and his very close
friend; another good friend, Edwin Churchill, professor of
surgery at Harvard; and many others from the rosters of
medical history.
"They all had the concept of providing for their trainees
the facilities and the atmosphere to think for themselves, to
discipline themselves as far as hard work and the care of the
patient was concerned and to push the frontiers forward
and learn more about the field in which they were working,"
Schwartz says.
"And to do that , they made it possible for their men to learn the
techniques as well as the art of medicine - of surgery - and the
ability to seek out answers, both in the clinic and in the laboratory.
And all of these wonderful individuals - almost all of them 
had somewhere along the line taken the time to pursue basic
scientific work."

t"Y
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OSt of the great contributors to surgery and neurosurgery,
Schwartz knew personally. His life, he says, has been "a
constellation of fortuitous events."
"Environment, luck - good or bad - and fortuitous
events make us what we are," says the man who in 1924, at the
age of 15, entered Princeton University knowing that he wished
to become a neurosurgeon . It was at Princeton that Schwartz
conducted his first brain surgery on the earthworm, " the
lowliest creature."
Because of its ability to regenerate itself, the earthworm
was an ideal subject for Schwartz, who was interested in
learning the process involved in regeneration. He began to
study its nervous system, removing the main cerebral

ganglia, the nerve centers. " I became
fairly adept at removing these ganglia
and then watching them grow back,"
he recoJlects.
Schwartz continued this research at Johns
Hopkins School of Medicine, where he en
rolled after receiving his bachelor of arts
degree in 1928. There, he worked with
anatomy professor Marian Hines.
"She was certainly my guiding
light," he says. "She had heard that I
had done this work at Princeton and
she asked me about it. She thought I
ought to continue it. That began a life
long relationship. She was a superb
woman, one of the finest women in
the world."
Hines - as well as other prominent
anatomists and biologists at Hopkins 
greatly int'luen.'ed Schwartz, who during
that period realIzed his lifelong interest in
anatomy and the nervous system. At the
same time, he was inspired by c,inicians;
some of the greats of surgery and
neurosurgery worked at Hopkins in
those days.
After receiving his Doctor of Medicine
degree in 1932, Schwartz interned in gen
eral surgery under Dean Lewis, M .D.,
then head of surgery at Hopkins, and
passed instruments to Walter Dandy,
M .D. Dandy 's renown as a neurosurgeon
at least equaled that of Harvey Cushing,
M.D. , who had been trained by Halsted
and who in tum trained Dandy at Hop
kins before joining the faculty at Harvard
Un iversi ty.
During the latter
part of his internship,
Schwartz was invited
by Dandy to stay on at
Hopkins. Although he
was intrigued by
neurosurgery,
Schwartz opted
instead to
pursue
anatomy and
neuroanatomy
as a National
Research
Council FeJlow
at Harvard.
The one-year
fellowship
stretched to two,
and Schwartz found
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have a wife who can not only speak the same lang uage, but more
important, can understand and sympathize, worry, cheer you up
and help you to maintain your own sanity and a certain
amount of equan imity.
"She has equan imity in tremendous amounts and has been
a tremendous factor in everything I've done." EJ ith Robinson,
MD. , is a clinica l assistant professor emeritus of pediatrics at the
School of Medic ine.
Of the sti nt at Harvard, Schwartz has said, 'Those were three
very good years.
indeed a happy time. " H.c decided, however,
to return to clinical work , and that was how Schwartz ended up as
Sachs' fellow at Washington University.
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himself with "one
foot in both camps,
anatomy and neurosurgery." At
that point he was "still waivering" and
received a position as instructor in
anatomy at Harvard.
It was in Boston that Schwartz and
his "very attractive, very bright" medical
school classmate, Edith Courtenay
("Reed ie") Robinson , were able to marry.
Back then it was "very rare, almost unheard
of," for a medical student or resident to
marry. But for Schwartz, marri age to
Reedie was clearly the most fortuitous
of eve nts.
"She is the most fo rtunate thing th at ever
happened to me," he says. "From her, I sub
sequently realized how vital it is. . to

24

hose were the formati ve days of neu rosurgery at
Washington University School of Medicine and else
where. The SI. Louis program, like all neurosurgery
programs then, was not formalized. The fi rst specialty board, the
Amer ican Board of Neurosurgery, and spec ific requirements for
certifica tion were established during World War II.
"Until then, the requirements were very vague, " Schwartz
explains. "If the chief of the service that you'd been working on said
you were okay to take the boards, well, that was all that was needed."
At Washington University, the Schwartz's came into daily contact
with people who since have become institutional cornerstones:
Phillip Shaffer, Carl and Gertrude Cori, JO(; Erlanger, George
Bishop, Evarts Graham, James O'Leary and many ot hers. These
early contacts, which developed into warm friendships, were possi
ble because the school was smaller then, Schwartz comments.
"In SI. Louis in those days.
it was easy to get to know other
indiv iduals in other departments on both sides of the street, the
pre-clinical side and the clinical side ... The competition along
with camaraderie was there ; likes and dislikes were manifest. But
nevertheless, it was relatively easy to get to know people and to
exchange ideas."
In particular Schwartz remembers IUIlchtime discussions in
which faculty from both sides of the street would eat lunch to
gether and talk about thei.r experiments.
Schwartz found time for those lunches, but it wasn't easy with
the work load he had under Sachs, "an extremely tough task
master. There were no nights off, there were no weekends off,
there were no days off. You were expected to meet the professor at
6 or 6:30 in the mornint.' and then make a quick rou nd before
going into the operating room. We did all the x-rays ourselve, 
the air injections, posi tioning the patients and so on - things that
we don't do anymore.
" After operating, Dr. Sachs would usually go to his office
downtown at the University Club building, or he'd stop at the lab
office across the street and dictate hi s notes and then go down
town. Meanwhile, we made rounds and took care of the chores.
When he'd come back in the late afternoon, at 5:30 or 6, we'd
make rounds again. And if there were new patients who had come
in, we'd have to work them up and dictate the notes, write the
orders and then start all over aga in. That was just the way it was."
At the time, the only neurosurgery lab was a pathology lab that
Sachs supported with his own funds. Although Sachs would have
prefer red Schwartz to help section and examine tumors in the
neuropat hology lab, Schwartz gravitated to the lab of neurophys
iologist George Bishop.
"Those of us who were interested in neurophysiology and that
kind of research worked with Bishop in his lab on the eighth floor
of McMillan ," he remembers. " We worked up there on all our
experimental work daily, by his good grace, reall y.
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"We were all rdat ivdy young. Of course, Dr. Bisllop wa~ many
stages beyond u~. but he wa., very. very happy to have people
working with him. He was a tough investigator, but a damn good
one. and a superb mentor. We were very luc ky."
Over tIle years. Schwartz's projects yielded a number of sign ifi
cant advances. With ~mo t her fell ow, Alan Kerr, he achieved the
first direct recording of electrical act ivity from the exposed human
brain in the Un ited States. Using a cathode ray oscilloscope that
Schwartz built and sil ver ball electrodes, they were able to record
thi s activity in the brief five mi nutes Sachs allowed the m.
" It was so amateurish it's laughable, when I thin k back." he
says. "compared to just a fe w years later, and particularly now.
But back then, live nunutes was pretty generou s because Dr.
Sachs was worried and so were we. His feeli ng was 'You 're
wasting ti me here. YOll have the patient '~ brai n ex posed and you 'd
better be doi ng something for the palien! instead of fooling around
with this business.' "
Later. whe n Schwartz was at City Hospital, he conducted one of
the first randomized studies in neurological surgery on the effect of
lu mbar punct ure in reducing intracranial pressure in severe head
injuries. 'There was a question whether every pat ient with a head
inju ry should have a lumbar puncture . . Some people thought it
would be dangerous, actually, if there waS too much pressure up
above. so that was why we rail th is series" The study concluded
that those cases could be handled without repeated spinal pu nctures.
Also at City Hospi t.11, Schwartz. c'-'veloped medullary trac
totomy, an operation for intractable, or unrelieved, pain. The oper
ation involves putting :' lesion in the medulla, a part of the brain
stem, to interrupt pain pathways ancl relieve severe facial pai n.
T hough it 's no longer necessary, althe ti me it was "a pretty good
operation. and it helped to elucidatc some of the anatomy" of pain
pat hs through the brain stem.
After World War U, he became enchanted with cervical
cordotomy, wh ich he also developed , to abolish intractable pain at
a high cervical level. The procedure elill1 in a te~ pilin in the lower
extremities, by operat ing in the neck rather than the brain stem.
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is ab reeding ground for surgeo ns," Schwartz has
said . "Whether we like it or not. we have to admit
that for surgeons the experience -the treatment of
wo unds, treatment of iniect ion. the basic thi ngs one could learn
about the physiology of the engine, the physiology of various
organs - this is an experience which I think should not be over
looked. Not that r advocate war as a part of training . It's a disas
trous sit uation. But nevertheless, the experiences gained in war
can be put to good use."
In 1941. Schwartz joined the medical unit affiliated with Wash
ington University and Barnes Hospital as assistant chief of the
surgica l service. He was fortunate in his a ~s ig n ments, he says,
because they allowed him to learn and to contribute to the knowl
edge of neurosurgical hand li ng of wounds to the head and nerves.
Ln Afri ca, he encountered trying times. His equ ipment had been
sunk , making it. of course, diffic ul t to operate. Yet he managed.
"We ~tole some equipment." he laughs. " Until we got that. I
carried a cW'ctte alld a rongeur my wi fe sen t me. And we had a
bayonet forceps, but we did not have a cautery; we did not have
clips. We had a drill that we stole. In most cases, the sku ll was
already part ially opl'n from the wound, and then with a rongeur
you could en large the hole."
T he hot cautery they devised is "incred ible in this day and age.
We used an alcohol lam p next to the operating table and when we

got a bleeder that was too smal1 ro tie off.
well we'd use the foreep~ - tum around,
heat the bayonet until it got hot and then
touch the bleede r. "
Despite the hardships in Africa.
Schwartz maue <;ignificant contributions
and, in fact, was responsible for changi ng
military procedure on how to tre.1t injuries
to the head and nerves. Policy had been to
leave con taminated head wounds open to
drain . That led, however, to inc reased infec
tions, hemiations of the brain and a high
morta li ty rate. SchwartL and his team
learned that the death rate could be tre
mendously reduced by cleaning wou nds
thorough ly and Llsing prec ise surgcry.
The same held true for nerve injuries.
Under Schwartz , the policy was to debride
nerve wounds, permi t them to heal ,md (hen
lhree to four week s later operate on the
nerve. That approach bettered soldier.,'
chances of recoveri ng function.
"The re were contaminated wounds. you
see, because in the African campai!!n evat u
ation was so bad we'd get patients up to sev
eral days after they'd been wounded before
anything
was done for
thtill . And
here were dirty.
contami nated
wounds thaI
ordi narily we
wou ld have just
cleaned up a
little and left
open to drain.
But we fonnd it
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late 1960$ when, a., ncurol>urgical cOl1sulwnt to the Slirg on
Genera l. he travck:d to Vielnam to observe neuro\urgery in
the held.
Al~o, from 196. 67 he tuok on the position of acting head of
the Department of urgery and acting surgeon-in-chief at Barnes
Ho~pila l in addition to his responsibilities as neuro,urgery head
,md nellro~lIrgcon - in - l' h ief at Barnes, Chi ldren's und Jewi~h
ho~pitals.

was ~l 10 operate on
th m, cut out all the dam
aged ti ssue and th n close
them up. So that necame the
general policy in Africa."
fter Africa. Schwa rtz ~er ved in
Algiers, Italy and France. Just before
his discharge, he completed a brief
stint as chief of neurological surgery at
Kennedy General Hospital in Memphis in
1945. T hat year he wa!> awarded the mili 
l<lry 'S prestigious Legion of M rit , and in
1946 returned to Washington University,
where Evarts Graham named him professor
and heal! of neurological surgery.
This. Goldring has said, began the phase
of hi~ life when most of American med icine
believes Schwartz made his greatest con
tri bution, training neuros urgeons. Goldring.
in writin!!, about Schwartz. has noted, "he
has always de-( mphasized the role of the
teacher, arg uing that it is of firs t importance
to ' pick a good man; the reafter h learns,
you don't teach him.' i
. bel ieve that
in his modesty he tells but half the story.
Equally important i, the fact that the pro
gram director cares."
Alt hough his residem:y training program
was Schwartz's most con~umin g interest as
departm nt head . he has served steadi ly
as a neurosurgical consu ltant to tlw Army
and th Veterans Admini stration . His most
acti ve period as a consultant wa.., dllring the
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In 1970. be was named Ihe Augu ~1 A. Busch Jr. Pnlf~ssor of
cu rologicaJ Surgery and lour years laler stepped down as head or
the department. Rather than slacken his pace, Schwanz chose to
use his extra lime to begi n new projects.
H became editor of the prestigious }OIlI'f/<1{ (~INeilro.\1/rgl!ry in
1975. ostensibly for three year~. ine yea rs later. the job - a
demanding one - was turned over to his former student, Collin5.
Schwartz aJ. 0 was instrumental in estab l i~hing the craniofacial
reconstruction program at the medical center in 1979. Accord ing
to the program director Jeffrey Marsh, M.D. , "If it had not been
for him and his willingness to not only lend his intellectual and
~p iri tual support, hut to be physically involved a~ the ncurosur
gl on and to spend many long hOllrs doing thal- ,on of devdop
Illg a whole new career at the end of hi, career - J th ink we
would have had great trouble gelling otf the ground ."
Schwartz himself says he became "cnamored" with craniofa
cial work , mw:h prefernng ilta "ordinary tumors." He stopped
serving as neurosurgeon for the craniofacial cases about two years
ago. but remains interested . 'Ii) this day, Mar h po i nl~ OUt ,
Schwartz ~e nds him articles related to craniofat:ial reconstruction
and follows up Illl favorite patients when they come in
lor checkups.
, chwnrtz's Iate~t project is the Vietnam '-lead Injury study, the
mo"t comprehensive study ever conducted of penetrating head
i l~uries. He i ~ one of fi ve members of a direelOratr..: that owrsces
thi~ Department or Defense qudy.
The nngoing 'mldy. which began in 191)1 , compares .-20 brain
injured veterans to 85 uninjured veteral1l>. Data collected from the
study have demonstrated improved neurosurgical and neurological
managemcnt of bm in injuries and illustrated how brain inju ries
affect tl inking. Ill~mory and mood . Researchers are now analyz
ing data for in~ights into cognitive disability, social adjustment,
mood, intelligence ,md mher p ychometric variables.
Schwartz has received virtually every honor in neurosurgery.
including the Distinguished Service Award from both the Amcri
can Board of Neurological Surgery and the Society of Neuwsur
gl:!ons, the Harvey Cu~hing Medal from thc American Association
of Neurological Surgeons und eJeclion in 19H5 a~ honorary pre~i 
dent of the W()rid Federalion of Neuro~urgical Socidie . He i a
I1lcmbn or thl:' Joh ns Hopkin" Society of Sch()l~ and i~ profi l d
in "Leader~ in American Medicine," a videotape made for the
AOA National Library of Medicine.
J Ie has held Illany appointments. alllong Ihem chairmanship of
lhe American Board of euroiog ical Surgery. pw,idency of ::l ll the
major nellro~urgi c al societies, und vice presidency of the Ameri
can College Df Surgeon~ and the American Surgical A~s\lc i ation .
In 1981 hi~ colleagues and former rc idents cstab li ~hed the Henry
G. Schwartz Lecture hip, now delivered annual!. at the School of
Medicille.
"As of July I, I completely qU it operating." Schwartz says. He
is a fam il iar sight in the halls. with his distinguished," hite hair.
tall !)parc frame and a walk that he sort of !Lans into. a. though
he's impatient to get to his deqination. Hi ~ interest. he huckles. is
"survi ing - sur iving day to day" Rut, he add." "I ~t iII do a
little work around here. ,. •
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Alumni Usher in New Loan Program
In addition to formal recog
nition. the evening's events
provided donors and students
a more infomlaJ chance to
meet. Those students who
received namcd loans wel
comed the special opportunity
to meet and thank their donors
one-on-one.
Named loans established
under the progranl were made
possible by the Dr. Joe M.
Boyles Memorial Ll,an Fund,
established by Mrs. Joe M.
Boyles; the Dr. and Mrs.
Robert C. Drews Loan Fund;
the Dr. and Mrs. Marvin E.
Levin Loan Fund ; the Loan
fund in honor of Dr. Eli Robins
and Dr. Samuel Guze, estab
lished by Dr. T homas F.
Richardson; the Dr. and Mrs.
Henry G. Schwartz Loan Fund;
the Dr. and Mrs. William L.
Topp Loan Fund; the Dr. and
Mrs. Mitchell Yanow Loan
Fund; and the Washington Uni
versity Med ical Center Alumni
Association Loan Fund .
Annual programs chairman
Robert C. Drews, M.D. , who
spearheaded the loan program
fundi ng, concluded the short
program that followed dinner
by wishi ng the students the
best for the future and assuring
guests that the students "can
be confident that they arl
achieving the best. Washington
University is one of the best
because it has one of dle best
student bodies."

wenty-Ilve students and
their benefactors
ushered in the new
Medical Scholars Loan Pro
gram by wining and dining to
gether tbis past September at
SI. Louis' Racquet Club East.
The program was estab
lisbed last year in an effort to
help students meet the high
cost of medical education with
interest-free loans, thereby up
holding tbe long-standi ng prin
ciple that no student should
have to torgo medical educa
tion at Washington University
because of fi nancial duress.
Alumni and friends contrib
uted a total of more than
$36,000 to the program, which
was matched by the Washing
ton University Medical Center
Alumni Association LO estab
lish 25 interest-free student

loans.
Summing up donor 5enli
ments, Henry G. Schwartz,
M.D.. August A. Busch Profes
sor Emeritus of Neurosurgery,
explained his reason for estab
lishingone of I I named Joans:
"These students need money to
help them get through school;
they're all broke. It's important
for us Lo make it possible for
good candidates to come here
and SLay here."
The Alumni Association's
Executive Council, which met
prior to the cocktail recepuon
and dinner. announced its in
tention to do just that - by
matching this year's coming
donations to the program up to
$50,000. Presenting a check for
$36,914 to Samuel B. Guze.
MD., vice chancellor tor medi
cal affairs. Donald G. Sessions,
MD '62, president orthe
Alumni Association, described
his group'S contribution as "a
gift l"hat can only match the in
terest and concern of aJwnni
towards their medical school ."

1bp: Washingtoll University jas/rifm iksigll students entertain
spouses dlUing the Executive Cc,mci1 meeting. Cmter: Tara Ann

Rumbarger and her donor, Mitchell Yanow, enjoy dinner oJ the
Racquet Club East. Bottom: Man,in E. Levul alld senior studelll,
Robert W. 1Olml, enjoy each other's company aJ the Medical
Scholars LoaJI Program DinJler.
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Free- interest loans aid seniors
throllgh final year

, ,

'The fact that alumni
have donated money
to help us out has
really boosted student
morale."

he mo t important
thing is not to get
bored with your job,"
Barbara M. Scavone, M.D. ' 87,
says of medicine and of life in
general. "No matter how much
work you have or how little
sleep you get, you have to look
at it as fun, or you'll never
survive," she says.
Taking time to relax and
pursue outside interests off the
job is one way to avoid bore
dom on the job, according to
the School of Medicine sen ior
from G len Ellyn . Illinois. " If
you live, dri.nk and eat medi
cine. you're going to burn out,"

she remarks. "1 find that I'm
much more enthusiastic about
my work when I put aside an
hour or two each day to sew or
read a good book."
Finding the time and place
tor her favorite extracurricular
activity - the piano - is diffi
cult at times, but she practices
at the student dormitory, Olin
Hall , whenever she can. 'The
piano's not exactly the IYpe of
instrument you can carry
around with you ," she says. "I
realJy njoy sitting down at my
mom 's piano when ['m home. "
Scavone has been hammering
ivory since the age of six, but
her musical talents are by no
means locked to the keyboard.
She sings in her mother's
church choir on Christmas and
has sung in the School of
Medicine's class show. She
laughingly admits that her ath
letic abilities leave something
to be desired , even though
she plays intramural soccer
on "the worst team in the
whole school."
Scavone is one of 25 chool
of Medicine students to benefit
from the Washington Univer
sity Medical S holars Loan
Program. Hers is one of three
named loans established by
Elsie Boyles in me mory of her
late husband , Joe ~t Boyles,
M.D. ' 30. "We're all carrying
such a huge amount of debt
these day that an interest-free
loan like this is greatly appre
ciated," Scavone says. "The
fact that al umni have donated
money to help li S out has really
boosted student morale."
Scavone, who plans to start
a reside ncy program in internal
medicine next fall , came to
Washington University from
the University of nt inois at
Champaign-Urbana, where she
majored in biology and psy
chology. Although she de
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scribes her fir t two years at the
School of Medici n as "too
many lec tures and too much
memorization," she found her
self really loving her third year
on the wards. In addition to en
joying the interaction with pa
tients and freedom to organize
her own time, Scavone finds
most of the attendings willing
to take extra time to explain
things. "It's that e tea five min
utes here and there that makes
the dit'fercnce ," she explains.
Scavone has selected inter
nal medi ine as her specialty
area because it is somewhat
less focll sed than other spec ial
ties, allowing her to " keep my
sights on the whole picture."
She is looking forward to a
four-week extemship in Lon
don, whe re sh will work in an
intensive care unit. " It"ll be in
teresting to compare the two
phi losophies (of socialized and
private medicine)," she says.
" I' ll be spending about the
same amount of time on the
CCU unjt at Jewish H spital
before I go. "
Scavone sees the di stri bu
tion of health care as the singlc
most important challenge fac
ing her generation of physi
cians. "A dichotomy of care is
developing between the rich
and poor," she says. 'For ex
ample, this ci ty has two
magnetic r 'onance imaging
facilities - one at the VA and
one at Barnes. Yi t there are
people coming into the VA who
are suffering from TB and can
not even alford to eaL W hat
good is that technology to us, if
we can't even solve endemic
TB? We need to keep in mind
that medicine is something for
people." 
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hen he was in fo urth
grade, Anthony C.
Griffi n, M.D. '87,
wanted to play the drums. His
parents couldn't afford to buy
their son a drum set, however,
so tbe young Griffin learned to
play the trumpet on his cousin's
coronet. He remembers his
parents encouraging him to
keep playing, even thougb, at
one ti me, he wanted to quit.
"They knew then that the
trumpet was somctiling J could
enjoy tor the rest of my life,"
he says. "From this I learned
the value of nOllelting yourself
quit just because you want to."
lbday, more than a dozen
years later, Griffin sti ll plays
the tr umpet , while pursuing a
passion for medic ine that began
almost as early as his first mus
ical notc. His ini tial fascination
with medicine stemmed from
frequent childhood visits to
doctors, hospitals and clin ics
he made with his two asthma
tic brothers. O nce planted, his
interest in mcdicine took root
during bigb school when he
participated in a science and
health opportuni ties program
sponsored by the Universi ty of
Wisconsin , Madison .
When it came time for him
to graduate, the high school
football star from Kenosha,
Wisconsin, who had already
accumulated college credit,
was a prime candidate for col
lege recruiters. Griffin was
offered scholar ships at several
prestigious institutions, among
them the School of Music at
the University of Califomia
Berkeley. He decided upon
Brown Universi ty because the
ivy league school placed
more emphasis on education
than athletics.
During his freshm an and
sophomore years as a premed
at Brown, Griffi n played the

receiving position on the foot
ball team . And during his
sophomore year, he played the
tru mpet in a local jazz band.
Now a senior medical student
at Washington University,
Griffin finds his soon-to-be
alma mater si milar to Brown in
terms of its high degree of per
sonability and support from
administration and fellow stu
dents. He views his recent re
ceipt of a named, free-interest
loan as " testamen t to how
concerned Washington Univer
sity is in terms of its students."
And he was impressed with the
dinner that was held in con
junction with the establishment
of the loans. "They could have
just handed out the loans and
said , ' Here you go.' It was just
another example of how Wash
ington University is a first
class place."
Griffi n plans to pursue a
career in plastic surgery,
remaining in St. Louis for his
residency. so that he and his
fiancee, Colette, a native of
St. Louis, can marry this Feb
ruary. Surgery appeals to him
because "it gives you the abil
ity to intervene, to make direct
applications to pathophysiology
and obtain inuned iate personal
gratification. " And he believes
plastic surgery suits him be
cause, "it is so diverse, you can
do anything from a face lift to
tendon repair to reconstructive
surgery. It's also technically
appealing because it's so
sophisticated. "
Gri ffin would like to some
how contribute to medical re
search, having already spent a
year investigating the role of
glucotrienes in hydronephronic
rabbit kidneys through the
M.D./Master'$ program at the
School of Medicine.
He 1110St definitely believes
that programs such as the Med

11 11111
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ical Scholars Loan Program
will encourage current students
to be good alums. "It has to
start somewhere," he says.
"Alumni coming back, alumni
giving is what keeps it all
going. It's that continuity that's
so important. " 

/'

'H was just another
example of how Wash
ington University is a
first class place. "
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Glen F. Irwin, M.D. '30,
was selected by the Wisconsin
Bureau of 1i urism to have his
color slide of a loon on the
billboard advertising the
tourism logan , "Escape to
Wisconsin." Dr. Irwi n's tide
was chosen from 100 other
slides submitted to the bureau .
A retired surgeon, Dr. Irwin
and hi ' wife, Jane, live on
Planting Ground Lake, Wis
consin , where they are active
loon watchers.
Cramer D. Reed, M.D.
'41 has become director of an
employee health management
and fitness program called
Health Strategies. A division of
the Wesley Medical Center in
Wichita , Kansa the program
features employee health pro
motion , cardiac rehabi li tation
community health education
and a 2,000-square foot fitness
center.
James H. Cravens, M.D.
' 43, has been elected to a
three-year term as president
and chairman of the nIinois
chapter of the American
Academy of Pediatrics. The U
linois chapter is one of the
largest in the academy, with
more than 1,200 pediatrician
members. Cravens has been a
member of the Physicians and
Surgeons Clinic in Quincy
since 1948. He is al 0 a mem
ber of the Academy 's commit
tee on hospital care, Presid nt
of the Swanberg Medical
Foundation of Adams County
Medical Society. Past-President
of the Adams County Medical
Society and the Downstate
IlLinois Pediatric Society, a
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Diplomate of the American
Board of Pediatrics and a Fel
low in the Am rican Academy
of Pediatrics.

60.t;
Oliver J. Biederman,
M.D. '58 FRS recently ran
his twelfth marathon. He is
currently th physician in
charge of the Kaiser Perma
nente facility in Lan aster.
California where he empha
sizes health maintenance and
physical fitness.
C. Craig Tisher, M.D. '61,
wa'! recently elected to the
Council of the American Soci
ety of Neph logy.
Anthony E. Falhman,
M.D. '64 is serving a one
year term as president of the
American College of Surgeons'
Missouri chapter.
Roger L. MeU, M.D. '65,
was recently elected Vice-Pres
ident of th Southern Merucal
Association a 50,OOO-member
voluntary association of pbysi
cian'! dedicated to fostering
scientifiC medjcine.
Richard H. Weisbart,
M.D., '65, was recently pre
sented the Philip Hench Award
by the A sociation of Military
Surgeons of the United States
for outqtanding contributions in
the field of rh umatology and
arthritis. A professor of medi
ci ne at the University of
Cali fornia Los Angeles, and
chief of rh umatology at the
Veterans Adminjslration Medi
cal Center in Sepulveda,
California, Weisbart is actively
involved in human lymphokine
research.
Jerome H. Kaplan, M.D.
'66, was recently named one of
86 fellow by the American

College of Radiology' Board
of Chancellors.

Wendy R. Eider, M.D. '76,
FHS, i' in solo practice in
rheumatology. She and her hu 
band. Darry D. Dernfeld,
M.D. '77. who is a urgeon ,
live in Yakima, Washington ,
with their three-and-a-half
year-old daughter, Jessica.
Faith B. HOlcoOlbe, M.D.
'80, FRS, writes that she and
h r husband, Fred Fiedoreck
Jr., M.D., a graduate of Harvard
Medical School. are thrilled
with Lheir daughter, Elizabeth,
wh ) was born January 31 st and
"is already demonslrating
a thirst for knowledge by
ehewing on our journals."
Robert W. Laakman,
M.D. '80, FHS, is a partner in
Radiology Associates P.A. in
Little Rock, Arizona, where he
live. with hi wife, Sheree, and
children: Petl;. 3Yz and Anna,
two months.

ieal obstetrics and gynecOlogy,
died Oct ber 29, 1986, at the
age of 82 . A devoted faculty
member, alum and community
member, Soule served as chair
man of the Dean's Committee
at the School of Medicine for
five years; as historian, corre 
pondent and reunion chairman
for his medical class; as cbair
man of the Alumni Relations
Committee and as Vice Presi
dent of the Alumni As ocialion.
He also was an Eliot Society
member lor many years.
SouJe was on the staff of
both Jewish and Barnes hospi
tal , having served as chief of
obstelrics and gynecology and
president at Jewih .
He contributed to more than
75 publications in his field and
was a member of the American
Medical Association , tbe Mis
souri Medical Association, the
St. Loui . Medical Society, the
American College of Ob telri
cl.an and Gynecol gi ts, the
Ameri an Fertility Soci ly, the
American Society of Psychol
ogy, the Academy of Science of
St. Louis, the St. Louis Gyne
cology Society ,md th Jewi h
Federation of St. Louis.
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Mixing Medicine and History
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mmet E Pearson. M.D.
'30, is a great believer in
serendipi ty. "You do
one thi ng," he likes to say, "and
something else lurns out better
than you had expected ," After
all, he stored one antique phy
sician's desk in his basement 
and soon amassed a medical
history collection . Then he
helped plan a medical lichool
for his hometown of Spring
field, Illinois - and it provided
the ideal framework for a
new medical history museum
named . in hL.. honor, The
Pearson Museum.
The 9-year-old museum
pays tribute to the many physi
cians living and working in tile
upper Mississippi River basin,
whose ingenuity and dedication
have moved the field of medi
cine another haIting step tor
ward. G leaming showcases in
the large museum room, lo
cated on the SJU-Springfield
campus. display some of their
equ ipment. There are early X
ray tubes, ivory-handled bladder probes and
intubation devices that saved the lives of
children choking from diphtheria . A silver
double button, invented by a Chicago
surgeon in the 18905, joined a resected in

testine and sloughed off after healing.
''I'm sure that those who have an interest
in medical history are much more apprecia
tive of the wonderful things we have, which
have been bu ilt on those things that have

been discarded ," says Pearson,
emeritus professor of medical
history, who has lectured
extensively in the United States
and Europe on medical
history topics,
The museum is also a tribute
to the vision of Pearson , a
remarkable local physician
who chose to bypass life in the
big city for a successful career
in Springfield. For more than
50 years, this 1930 Washington
University School of Medicine
graduate has maintained a
private practice in internal
medicine, while serving in
such local leadership roles as
Chairman of the Department
of Medicine and President of
Staff at Memorial Hospital.
Along the way, as he modestly
admits, he has been personal
physician to two Illinois gover
nors, one of them White House
aspirant Adlai Stevenson.
"Dr. Pearson is an elder
statesman of Springfield's
medical community, held in
high regard as a physician, teacher and
community leader," says Jack Siefkas,
former director of medical alumni and
development programs, who met Pearson
while working at SIU-Springfield. "Along
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with being a role model, Dr. P arson also
has shown a warmth and chann to everyone
associated with him. "
As a founder and former president of the
Sangamon County Historical Society. Pear
son is deeply involved in historic preser
vation. A few years ago, he and his wife,
Mary, discovered a century-old agestop in
nearby Clayville restored it and presented
it to Sangamon Stale University He has
long worked to give the Springfield area a
broader view of itself. 'Everytrung used to
be Abraham Lincoln here. People feel that
nothing happened before Linc In came and
nothing has happened sinc ," he says.
But inevitably, he too has gotten caught
up in Lincoln. In hi. museum , there are
Jedg r pages showing Lincoln's purchases
from a local drugstore. After careful re
search , Pearson has formed his own opin
ions about L incoln' health. Lincoln was
meianchol.ic, covering up periods of depres
sion by teUi ng jokes; he had indig tion ,
wruch was never fuIly diagnosed. Most
controversial of all. Pearson says. Lincoln
may have had venereal disease.
Pearson was born in the hills of Thnnes
see near the Miss! sippi rder. H is father
ran a count ry store and the famjly farm,
former ly a plantation; his grandfather was a
Confederate C ivil War veteran held prison
er by the "damn Yankees" in Memphis. "It
was still a 19th century way of life: no elec
tricity. no water works. no trans rtation
except horse-dra n vehi les" he says,
Aft r a year at the University of Mis is
sippi. he followed his brother to Washington
University, where Pearson fini shed his A. B.
in 1926. To earn money, he worked in the
cafeteria at night, climbing the ladder from
dishwasher to caEhier. During the summers,
he supervi 'ed t ms of magazine ales men
as they fanned out acro s the Midwest .
Pursuing a lifelong anlbition . he moved
on to the Washington University School of
Medicine and an internship/residency at
Barnes Hospital . T he fac ulty was an emi
nent group; two w n Nobel Prizes while he
was th reo He remembers particularly his
mentors David Barr, M.D.. Edmund Cow
dry, M D. and most of all, Evarts Graham,
M.D., for whom he did research into the
medical side of lung disease. "Many of my

professors now have portraits on prominent
walls at Barnes Hospital; they were such
great physicians," he says.
Following medical school, Pearson used
savings from his magazine job to finance a
six-month trip to several famou s European
clinics. He admired the French treatment of
nervous disorders and the German method
of demonstrating patients, brought to per
fection by Friedrich von Mueller, M.D.
Out of training in the midst of the
Depression , Pearson picked Springfield, a
state capitol with a reliable government
payroll , as a place to settle down , He had
specialized in internal medicine "since you
get a philosophical point of view along with
the scientific one, a 'holistic' approach." He
made a fortunate choice of sub-specialty:
the treatment of allergy. "
one had ever
heard of it, .0 other doctors referred their
patients to m ," he says.
Then war xploded in the Pacific. Pear
son had to leave his burgeoning practice
and young family to spend four years at
various military hospitals. A one-year stint
as commander of a large hospital in the
Philippines wa · the most harrowing. They
cared for the Manila elite, includj ng bishops
and supreme court justices, along with
wounded soldiers from the front lines just
a few miles away.
Back home, he took a job at Northwest
ern University, only to decide within months
that Chicago was "too big." He retumed to
Springfield and soon had prominent patients

in Governor Adlai Stevenson and, later,
Otto Kerner. 'When Stevenson was running
for the presjden , I was interviewed about
his health ," he recal l . "I aJways gave him
a good report· I thought he was healthier
than Eisenhower...
Before the 1968 state sesquicentennial,
Pearson took on a fateful role as chairman
o an flIinois State Medical S ciety commjt
tee setting up a medica l history museum.
They already had one ite m, a magnificent
walnut desk, custom-made for a Chi ago
physician just before the great 1871 fire
destroyed his office. Pearson stored it in his
basement, only to discover that funds for
the museum would not
vailable.
But medical history had been Pear 'on's
long-time hobby, Du ri ng medical school, he
belonged to a group of interested students
who met to di cuss hi storical topic . On his
way to Europe, he stopped at Joh ns Hop
kins University and "sat at the feet" of the
renowned William Welch, M.D., the first
professor of medical history in the US.
O nce his interest was rekindl d , he
started collecting - in earnest when space
in the new medical school was assured. He
acquired a campi Ie antique dru o tore with
a sheaf of prescri ptions and 207 apothecary
jars bearing such intriguing labels as
"myrrha," "pulvis rhei," or "crocus." He
also began his own collection , now on
display, of mail disinfected by various coun
tries llsing smoke fommldchyde or steam
in an effort to stem epidemics.
The museum, which will soon expand to
two new locations, also serves Pearson's
favori te purpose: a teaching forum for in
terested sru medical students. Each year,
some 10 percent of the student body studies
medical history, writing papers on such
topics as yellow fever epidemics or the late
Chief G ray Eagle, a patient of Pearson's,
who was the last Indian medicine man
in minois.
Pearson still can't resist picking up an
occasional museum piece. In their spare
time, he and his wi fe travel or enjoy their
four children and grandchildren . He shrugs
off retirement. '" ve been thinking abo ut it
for 20 years," he says. " but I don't get
around to accomplishing it. I guess I like
what I'm doing."
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Outlook Gets High Marks
.
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More than 20 years ago, when Outlook was first
published as an eight-page newsletter, Dean M.K. King
wrote, "We will begin modestly in size and scope,
hoping for a more expansive future. "
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At that time, he invited alumni and mem
bers of the Schtx)1 of Medicine staff to send
suggestions for the type of material to be
contained in future issues, keeping in mind
the publication's original goal: "to inform
the staff, and also the alumni residing in
Sl. Louis, of developments with which they
are not already familiar."
To determine how well Outlook has been
meetjng its original goal and new goals as
well, those responsible for Outlook once
again solicited readers' suggestions - this
time in the form of a four-page, mailed
readership survey conducted last summer.
One-hundred-and-eighty-five readers
responded to the survey, which was mailed
to a total of 500 randomly selected recip
ients of the magazine. Of these respondents,
36 percent were M.D. alums, 16 percent
were former house staff, 13 percent were
School of Nursing graduates, 10 percent
were allied health graduates, 7 percent were
health administration and planning gradu
ates, 6 percent were faculty members and
the remaining 18 percent included Ph.D.
alums, M.S.T.P. alums, non-academic staff
and students and their parents.
These reauers gave Ollllook magazine high
marks for overall quality and appearance.
Sixty-seven percent rateu the overall quality
of Outlook as excellent, and 28 percent
rated it as good. The magazine was rated
even more highly for its appearance, with
80 percent of the respondents marking
excellent, and 45 percent good. At least 90
percent of the respondents gave Outlook
good or excellent ratings for quality of
writing, photography and illustrations.

Outlook:\' coverage of basic research,
clinical research and patient care was evalu
ated as excellent or gooU by at least 80 per
cent of the respondents, while more than
half gave the magazine good or excellent
ratings for its coverage of students, general
issues in academic medicine, institutional
additions, alumni, faculty or institutional
changes, opinion and development. The
publication's coverage of nostalgia and
curriculum and education were rated as
needing improvement, with more than one
quarter of the respondents evaluating cover
age of these topics as fair or poor. Survey
results also included a significant number of
written-in suggestions to provide more
coverage of nursing and other allied
health fields.
Survey respondents marked feature
stories as the section they read the most,
followed by Newsbriefs, Class Notes,
Alumni Report, Silhouette, Personal
Outlook and Student Stage.
Readers' enjoyment of Outlook appears
to depend to a large extent upon its visual
effect. Ninety-six percent of the respon
dents marked that the color photographs
and illustrations enhance the magazine, and
53 percent admitted that these photos and
illustrations usually entice them to read a
particular story. The most frequently
marked reason for reauing a given story,
however, was that "it regards a topic that
interests me."
Outlook:~ readers appear to be satisfied
with how often it comes out, with approxi
mately 90 percent of the respondents
marking that the magazine should continue

to be published on a quarterly basis.
Seventy percent of the respondents prefer
feature articles that focus exclusively on re
search and people at Washington University,
while the remaining 30 percent would like
Outlook to include stories about people
and research outside the university. Almost
three-quarters of the respondents, however,
agreed that they prefer more and shorter
stories per issue, so that they can see a
wider range of topics.
On the whole, the Outlook survey found
its readers to be proud of the publication .
Approximately 68 percent of the respon
dents marked that they share the magazine
with a friend or family member at least
occasionally.
As survey results indicate, Outlook has
certainly come a long way from its humble
beginnings, with major strides having
been made in the last three years under the
direction of former editor Suzanne Hagan.
Those who continue to be responsible for
the magazine's production hope to make it
an even greater success in the future.
Readers' suggestions for a greater variety of
topics and more shorter stories have been
well taken, and the importance of the publi
cation's visual appeal also has been noted.
Outlook's new editor, Kathy Will, who
comes to the magazine from Northwestern
University Medical School where she was
associate editor of the alumni magazine,
will be working hard to make Outlook even
better with each new issue.
-The Office ofMedical
Public Relations
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Glutamate, which is found in high concentrations in the brain, is a
paradoxical molecuk, not only serving as a neurotransmitter and a major
building block for the fomwtion ofimportant brain peptides and proteins,
but also as a potential toxin. Studying the lekyU and Hyde properties of
glutmnak are Washington University School ofMedicine's own Drs. lohn
W. Olney and Madelon T. Price. See story, page 8.
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